Home
Tmunity Therapeutics

Tmunity Therapeutics Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domaintmunity.com

Year Founded2015

Employees51 - 200

Annual Revenue$50M - $75M

Tmunity Therapeutics

Tmunity Therapeutics (including company regionals)

tmunity.com

See more website traffic and engagement information

Tmunity Therapeutics Revenue up to May 2026 is 50M - 75M

revenue generated by Tmunity Therapeutics top domains

Tmunity Therapeutics top domains revenue over 3 years

Revenue for Tmunity Therapeutics top domains

tmunity.com50M - 75M

See more with Sales Intelligence

Total visits to Tmunity Therapeutics's top domains

Understand Tmunity Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Tmunity Therapeutics's top domains

Analyze Tmunity Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Tmunity Therapeutics's top domains

See how Tmunity Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Tmunity Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Tmunity Therapeutics

These are the website technologies, by industry, used by Tmunity Therapeutics top domains

Advertising (3)

DoubleClick

Business Solutions (2)

DocuSign

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

More Technologies

6

See all

News & Signals from Tmunity Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKango left Tmunity Therapeutics, Inc. as CEO on May 1st '26.Kango most recently served as CEO of Tmunity Therapeutics prior to its acquisition by Gilead, and currently serves on the board of Dianthus Therapeutics (Nasdaq: DNTH).

NewsTmunity Therapeutics, Inc. hired King as CFO on Jan 1st '20.In 2020, King became CFO of Tmunity Therapeutics, which was subsequently acquired.

NewsKaren leaves Tmunity Therapeutics, Inc. as Head of Clinical Development and Clinical Operations.Karen joins Adaptimmune from Tmunity where she served as Chief Medical Officer and previously as Head of Clinical Development and Clinical Operations.